Literature DB >> 22050820

Phage therapy pharmacology: calculating phage dosing.

Stephen Abedon1.   

Abstract

Phage therapy, which can be described as a phage-mediated biocontrol of bacteria (or, simply, biocontrol), is the application of bacterial viruses-also bacteriophages or phages-to reduce densities of nuisance or pathogenic bacteria. Predictive calculations for phage therapy dosing should be useful toward rational development of therapeutic as well as biocontrol products. Here, I consider the theoretical basis of a number of concepts relevant to phage dosing for phage therapy including minimum inhibitory concentration (but also "inundation threshold"), minimum bactericidal concentration (but also "clearance threshold"), decimal reduction time (D value), time until bacterial eradication, threshold bacterial density necessary to support phage population growth ("proliferation threshold"), and bacterial density supporting half-maximal phage population growth rates (K(B)). I also address the concepts of phage killing titers, multiplicity of infection, and phage peak densities. Though many of the presented ideas are not unique to this chapter, I nonetheless provide variations on derivations and resulting formulae, plus as appropriate discuss relative importance. The overriding goal is to present a variety of calculations that are useful toward phage therapy dosing so that they may be found in one location and presented in a manner that allows facile appreciation, comparison, and implementation. The importance of phage density as a key determinant of the phage potential to eradicate bacterial targets is stressed throughout the chapter. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22050820     DOI: 10.1016/B978-0-12-387044-5.00001-7

Source DB:  PubMed          Journal:  Adv Appl Microbiol        ISSN: 0065-2164            Impact factor:   5.086


  36 in total

1.  Pseudomonas aeruginosa phage PaP1 DNA polymerase is an A-family DNA polymerase demonstrating ssDNA and dsDNA 3'-5' exonuclease activity.

Authors:  Binyan Liu; Shiling Gu; Nengsong Liang; Mei Xiong; Qizhen Xue; Shuguang Lu; Fuquan Hu; Huidong Zhang
Journal:  Virus Genes       Date:  2016-04-06       Impact factor: 2.332

2.  Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections.

Authors:  Sharon S Y Leung; Thaigarajan Parumasivam; Fiona G Gao; Nicholas B Carrigy; Reinhard Vehring; Warren H Finlay; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Hak-Kim Chan
Journal:  Pharm Res       Date:  2016-02-29       Impact factor: 4.200

Review 3.  Phage Therapy in the Era of Synthetic Biology.

Authors:  E Magda Barbu; Kyle C Cady; Bolyn Hubby
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

Review 4.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

5.  Phage Therapy: Future Inquiries.

Authors:  Sijia Wu; Elisabeth Zachary; Keenan Wells; Catherine Loc-Carrillo
Journal:  Postdoc J       Date:  2013-06

6.  Effects of storage conditions on the stability of spray dried, inhalable bacteriophage powders.

Authors:  Sharon S Y Leung; Thaigarajan Parumasivam; Fiona G Gao; Elizabeth A Carter; Nicholas B Carrigy; Reinhard Vehring; Warren H Finlay; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Hak-Kim Chan
Journal:  Int J Pharm       Date:  2017-02-03       Impact factor: 5.875

Review 7.  Phage Biocontrol of Campylobacter: A One Health Approach.

Authors:  Sophie Kittler; Severin Steffan; Elisa Peh; Madeleine Plötz
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

Review 8.  Topical application of bacteriophages for treatment of wound infections.

Authors:  Rachel Yoon Kyung Chang; Sandra Morales; Yuko Okamoto; Hak-Kim Chan
Journal:  Transl Res       Date:  2020-03-19       Impact factor: 7.012

Review 9.  Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria.

Authors:  Bingqing Yang; Dan Fang; Qingyan Lv; Zhiqiang Wang; Yuan Liu
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

10.  Microplate-test for the rapid determination of bacteriophage-susceptibility of Campylobacter isolates-development and validation.

Authors:  Samuel Fischer; Sophie Kittler; Günter Klein; Gerhard Glünder
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.